Skip Ribbon Commands
Skip to main content
Menu
Clin Asst Prof Ryan Shea Tan Ying Cong

Clin Asst Prof

MBBS, MRCP (S’pore), MMed (Int. Med), FAMS, MTec (EBAC)

Consultant

National Cancer Centre Singapore

Specialty: Medical Oncology

Clinical Interest: Gynae-Oncology, Breast

Conditions Treated by this Doctor:
Breast Cancer, Cervical Cancer, Ovarian Cancer.

Clinical Appointments

  • Consultant Division of Medical Oncology National Cancer Centre SingaporeNational Cancer Centre Singapore
  • Consultant NCCS Oncology @ SKH Sengkang General HospitalSengkang General Hospital

Academic Appointments

  • Clinical Asst Professor

Profile

​Dr. Ryan Tan is a Consultant in the Division of Medical Oncology at National Cancer Centre Singapore. He is actively involved in Informatics research within the National Cancer Centre of Singapore (NCCS). Dr Tan completed his specialist training in Medical Oncology at NCCS, and is a Fellow of the Academy of Medicine, Singapore.

Dr Tan's sub-specialty interests are breast cancer and gynaecological cancer. His research interests include Informatics and Artifical Intelligence and their application in healthcare. His research team collaborates with various academic groups and industry partners to develop useful analytic platforms and tools for use by clinicians and researchers. Dr. Tan also works with digital health innovation teams in NCCS to advance value-based health care projects to tackle access and cost issues in healthcare. Dr Tan is also active in teaching Senior Residents, medical officers and medical students. He has received accolades for his education and clinical work.

Education

  • ​Masters of Technology in Enterprise Business Analytics, National University of Singapore (NUS), 2021
  • Fellow of Academy of Medicine Singapore, Chapter of Medical Oncologists, College of Physicians, 2020
  • American Medical Informatics Association 10 x 10, Oregon Health & Science University, 2018
  • Member of Royal College of Physicians (UK); Master of Medicine (Internal Medicine) (Singapore) 2014
  • Bachelor of Medicine and Bachelor of Surgery, National University of Singapore (NUS), 2010

Professional Appointments and Committee Memberships

  • Co-Chair, IT-Enabled Care Workgroup, NCCS
  • Member, Oncology Academic Program Quality Improvement Committee, NCCS
  • Clinical Tutor, Department of Medicine, Yong Loo Lin School of Medicine, NUS, Singapore
  • Executive Committee Member, Association for Medical and Bioinformatics Singapore

Awards

  • Special Recognition Award, Yong Loo Lin School of Medicine, NUS, 2020
  • Residency in SingHealth Excels Outstanding Resident Award, 2019
  • Residency in SingHealth Excels Outstanding Resident Educator Award, 2018
  • Best Resident Award, Department of Medicine, Changi General Hospital, 2015
  • Meritorious House Officer Award, Yong Loo Lin School of Medicine, NUS, 2011

Best Houseman Award, Department of Medicine, Khoo Teck Puat Hospital 2010

Research Interests

Publications

  • Tan HQ, Ong HH, Arjunan MK, Tan JYT, Tan RYC et al. Multi-center Evaluation of Artificial Intelligent Imaging and Clinical models for predicting Neoadjuvant chemotherapy response in Breast Cancer. Breast Cancer Res Treat 2021 (in press)
  • Cao JY, Tan RYC, Li ST et al. Identifying Ataxia Telangiectasia in Cancer Patients: Novel insights from An Interesting Case and Review of Literature Running head: ATAXIA TELANGIECTASIA AND CANCER. Clin Case Reports 2020 Dec 30
  • Chin XW, Ang ZLT, Tan RYC et al. Use of telephone intake for family history taking at a cancer genetics service in Asia. J Genet Couns 2020 May 5.
  • Rahardja, Tan RYC, Sultana R et al. Real world patterns of use and value of pertuzumab in the treatment of HER2+ metastatic breast cancer in Singapore: The National Cancer Centre Singapore experience. World Journal of Clinical Oncology 2020 Mar 24;11(3):143-151
  • Kwee GJ, Tan RYC, Sultana R et al. HER2 positive rates in Invasive Lobular Breast Carcinoma: The Singapore Experience. World Journal of Clinical Oncology 2020 May 24;11(5):283-293.
  • Tan RYC, Camat MD, Ng M et al. HER2 positive rates are enriched amongst colorectal cancer brain metastases: a study amongst 1920 consecutive patients. Ann Oncol. 2018 Jul 1;29(7):1598-1603
  • Tan RYC, Toh CK, Takano A. Continued Response To One Dose of Nivolumab Complicated by Myasthenic Crisis. Journal of Thoracic Oncology. 2017 Jul;12(7):e90-e91
  • Tan, RYC. & Tan, G.S. Value-Based Healthcare in Residency Training: a Perspective from Singapore. Medical Science Educator. 2017 June; 27(2): p423–426
  • Tan RYC, Met-Domestici M, Zhou K et al. Using Quality Improvement Methods and Time-Driven Activity Based Costing to Improve Value-Based Cancer Care Delivery at a Cancer Genetics Clinic. Journal of Oncology Practice. 2016 (3): e320-331
  • Tan RYC, Ngeow J. Hereditary diffuse gastric cancer: What the clinician should know. World Journal of Gastrointestinal Oncology. 2015;7(9):153-160.

Research Trials